These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 15182167)

  • 1. The managed care approach to placing a drug on formulary.
    Bronson DM
    Cutis; 2004 May; 73(5 Suppl):33. PubMed ID: 15182167
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmaceuticals issue brief: managed care drug formularies: year end report-2003.
    MacEachern L
    Issue Brief Health Policy Track Serv; 2003 Dec; ():1-8. PubMed ID: 14969259
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incorporating quality of life data into managed care formulary decisions: a case study with salmeterol.
    Bukstein DA
    Am J Manag Care; 1997 Nov; 3(11):1701-6. PubMed ID: 10178468
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Physician satisfaction with formulary policies: is it access to formulary or nonformulary drugs that matters most?
    Glassman PA; Good CB; Kelley ME; Bradley M; Valentino M
    Am J Manag Care; 2004 Mar; 10(3):209-16. PubMed ID: 15032258
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The use of drug formularies in managed care.
    Hill LA
    J Hosp Mark; 1999; 13(2):63-85. PubMed ID: 10915392
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Understanding, creating, and working with formulary systems.
    Quinn CE; Barisano A
    Am J Manag Care; 1999 Oct; 5(10):1311-7; quiz 1318-9. PubMed ID: 10622996
    [No Abstract]   [Full Text] [Related]  

  • 7. Managed care and physicians' perceptions of drug formulary use.
    Fang H; Rizzo JA
    Am J Manag Care; 2009 Jun; 15(6):395-400. PubMed ID: 19514805
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Formulary: what it is and how it works.
    Smith G
    J Healthc Resour Manag; 1996 Sep; 14(7):11-3. PubMed ID: 10161584
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of formulary restrictions on the cost-effectiveness of antidepressant treatment.
    Sheehan DV; Wright-Etter PJ
    Manag Care Q; 2002; 10(3):21-31. PubMed ID: 12476662
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The case for a value-based formulary: striving for total lowest net cost.
    Weart W; Bauman GR
    Manag Care Interface; 2007 Apr; 20(4):42-7. PubMed ID: 17474330
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Weighing the evidence: trends in managed care formulary decision making.
    de Lissovoy G
    J Clin Psychiatry; 2003; 64 Suppl 17():29-32. PubMed ID: 14680425
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determining whether managed care formularies meet the needs of pediatric patients.
    Smith PS
    Am J Manag Care; 1998 Sep; 4(9):1328-35; 1336-7. PubMed ID: 10185983
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The drug formulary decision-making process.
    Brehany J; Cohen P; Sax MJ
    Healthplan; 1999; 40(3):85-92. PubMed ID: 10538088
    [No Abstract]   [Full Text] [Related]  

  • 14. Increasing stakes and complex dynamics in the formulary process.
    Tadlock C
    Manag Care Interface; 2007 Mar; 20(3):12, 14. PubMed ID: 17458473
    [No Abstract]   [Full Text] [Related]  

  • 15. Pharmaceuticals issue brief: managed care drug formularies: year end report-2002.
    Morgan R; MacEachern L
    Issue Brief Health Policy Track Serv; 2002 Dec; ():1-7. PubMed ID: 12856686
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of health-related quality of life information in managed care formulary decision-making.
    Wu WK; Sause RB; Zacker C
    Res Social Adm Pharm; 2005 Dec; 1(4):579-98. PubMed ID: 17138497
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incorporating clinical outcomes and economic consequences into drug formulary decisions: a practical approach.
    Mather DB; Sullivan SD; Augenstein D; Fullerton DS; Atherly D
    Am J Manag Care; 1999 Mar; 5(3):277-85. PubMed ID: 10351024
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Managing drug costs: the perception of managed care pharmacy directors.
    Litton LM; Sisk FA; Akins ME
    Am J Manag Care; 2000 Jul; 6(7):805-14. PubMed ID: 11067377
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Managed care guidelines for the economic evaluation of pharmaceuticals.
    Langley PC; Martin RE
    Am J Manag Care; 1997 Jul; 3(7):1013-21. PubMed ID: 10173366
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Do P&T committees have enough power? Plans and PBMs are divided about sharing drug prices with clinicians. Is it better to have an administrative committee determine the formulary?
    Cross M
    Manag Care; 2007 Apr; 16(4):39-42. PubMed ID: 17491288
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.